TRANSINE THERAPEUTICS
Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
TRANSINE THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.transinetx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18.68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Google Tag Manager Font Awesome Global Site Tag Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Anavo Therapeutics
Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
eniferBio
Sustainably produced protein is one of the most important aims for the future food production.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Epidarex Capital
Epidarex Capital investment in Seed Round - Transine Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - Transine Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - Transine Therapeutics
Takeda Ventures
Takeda Ventures investment in Seed Round - Transine Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - Transine Therapeutics
Takeda Ventures
Takeda Ventures investment in Seed Round - Transine Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-23 | Transine Therapeutics poised for growth with new CSO hire and tripling of lab space |
Official Site Inspections
http://www.transinetx.com Semrush global rank: 6.53 M Semrush visits lastest month: 954
- Host name: raspberry.active-ns.com
- IP address: 185.136.250.2
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Transine Therapeutics"
Harness Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Harness Therapeutics is a private biotechnology company focused on the development of a novel class of …See details»
Transine Therapeutics - VentureRadar
Website: https://www.transinetx.com/ Develops therapeutic RNAs with unprecedented control and specificity using the SINEUP® platform, targeting ophthalmology and CNS ...See details»
Transnetyx - 2025 Company Profile, Funding & Competitors - Tracxn
Transnetyx - Developer of automated-genotyping services for murine cell lines. Acquired by Thompson Street Capital Partners. Raised funding over 2 rounds from 4 investors. Founded …See details»
Automated Genotyping PCR Services | Transnetyx
Transnetyx frequently hosts presentations for researchers. Find one in your area and reserve your seat. Check the schedule. An in-house hub for automated genotyping. This on-site kiosk …See details»
Transine Therapeutics - Craft
Jun 3, 2021 Transine Therapeutics has 5 employees at their 1 location and $12.56 m in total funding,. See insights on Transine Therapeutics including office locations, competitors, …See details»
Transine Therapeutics Closes Extended Seed Funding of £9.1 …
Jun 2, 2021 New Company emerges from stealth with potential ground-breaking mRNA therapeutic platform to increase protein expression. Cambridge, UK, 2 nd June 2021: Transine …See details»
Transine Therapeutics Closes Extended Seed Funding of £9.1 …
Jun 2, 2021 [email protected] . Citigate Dewe Rogerson Sylvie Berrebi, David Dible, Frazer Hall [email protected] T: +44 (0)20 7638 9571.See details»
Transine Therapeutics Announces Final Closing of its Seed Round …
May 31, 2022 [email protected] . MEDiSTRAVA Consulting Sylvie Berrebi, Frazer Hall [email protected] T: +44 (0)20 3928 6900.See details»
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle …
Dr Thirkettle is a seasoned life sciences executive with deep experience and a proven track record in building successful novel platforms. CAMBRIDGE, England, July 5, 2021 …See details»
Transnetyx Company Profile - Office Locations, Competitors ... - Craft
Transnetyx has 5 employees at their 1 location. See insights on Transnetyx including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Transine Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Transine Therapeutics. See Transine Therapeutics company profile and funding data.See details»
Transnetyx - Crunchbase Company Profile & Funding
Transnetyx is an automated genotyping company dedicated to serving research and saving time by removing redundant, yet necessary, tests conducted in genetic research. Transnetyx has …See details»
Transnetyx - LinkedIn
Transnetyx is an automated genotyping company dedicated to serving research and saving time by removing redundant, yet necessary, tests conducted in genetic research.See details»
About Us | Transnetyx
The mission of Transnetyx, then and now, is to help scientists accelerate research with fast, easy, and accurate real-time PCR genotyping. Fast forward to today, and Transnetyx has genotyped …See details»
Bob Bean - Founder, President and CEO at Transnetyx - The Org
Transnetyx has genotyped more than 25 million samples worldwide in 24 or 72 hours with 99.97 percent accuracy. It has built a genetic database of more than 20,000 assays and is the …See details»
Transnetyx Expands Offering with Genetic Sequencing Through
Aug 22, 2023 /CNW/ -- Transnetyx, a global leader in outsourced genetic services, ... Organization Profile. Transnetyx Inc. Related Organization(s) Laragen. Contact Cision. 866 …See details»
Biotech organization strengthens the lifeline of their business with ...
Jul 27, 2022 Biotech organization strengthens the lifeline of their business with modern, IP-based network and collaboration solutions Transnetyx is dedicated to providing their …See details»
Transnetyx Locations - Contract Research Map
The Transnetyx suite of services enables researchers and institutions to outsource critical tasks and functions – accelerating their paths to discovery. Individually and in combination, …See details»
Transnetyx Announces Acquisition of BrainBits® - Newswire
Feb 8, 2021 /CNW/ -- Transnetyx, a global leader in automated genotyping services, today announced the acquisition of BrainBits, a leading provider of fresh,...See details»
Working at Transnetyx - Top Workplaces
Transnetyx serves the laboratory animal research industry and provides laboratory consulting through an established, accurate, and cost-effective methodology. Transnetyx asks that each …See details»